Jan 15, 2002
According to new findings, programs designed to evaluate or improve cognition in people with MS are unlikely to produce significant results.
Cognition encompasses the mental processes of knowing, thinking, learning and judging.
The scientists recruited 240 individuals with proven or probable MS and randomly assigned them to one of three groups. Members of the assessment group had a thorough cognitive assessment, while members of the treatment group received the assessment and engaged in a program to reduce the impact of cognitive difficulty. Members of the control group, meanwhile, received only standard therapy.
The research team examined the subjects four and eight months after the trial, specifically looking at measures of general health, memory and daily living.
The investigators observed few significant differences between the three groups at either time period, and these differences actually favored the control group.
Furthermore, neither the assessment nor the treatment program appeared to have any effect on mood, quality of life, subjective cognitive impairment or independence.
The study appears in the current issue of Journal of Neurology Neurosurgery and Psychiatry.
Copyright 2000 FaxWatch Inc.